Clinical Trial Update: Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessed whether degarelix reduces prostate volume in men with prostate cancer; results have been posted following completion of the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Firmagon (Degarelix)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2012-04-11